Current Neuropharmacology
Title:Meet Our Editorial Board Member
Volume: 15 Issue: 4
Author(s): Cristine Alves da Costa*
Affiliation:
- Institut de Pharmacologie Moléculaire et Cellulaire UMR7275 CNRS/UNSA Laboratory of Excellence DistALZ 660 route des Lucioles, 06560 Sophia-Antipolis, Valbonne,France
Export Options
About this article
Cite this article as:
Costa Alves da Cristine*, Meet Our Editorial Board Member, Current Neuropharmacology 2017; 15 (4) . https://dx.doi.org/10.2174/1570159X1504170412205854
DOI https://dx.doi.org/10.2174/1570159X1504170412205854 |
Print ISSN 1570-159X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6190 |
13
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Detection of Predictive Markers for Therapeutic Stratification of Salivary Glands Tumors
Current Drug Targets Interleukin-24: A Molecule with Potential Anti-Cancer Activity and a Cytokine in Search of a Function
Endocrine, Metabolic & Immune Disorders - Drug Targets Emerging Facts on Chronic Consumption of Aspartame as Food Additive
Current Nutrition & Food Science Imidazoquinolines: Recent Developments in Anticancer Activity
Mini-Reviews in Medicinal Chemistry Clinical Trials with Oncolytic Measles Virus: Current Status and Future Prospects
Current Cancer Drug Targets Target Based Drug Design - A Reality in Virtual Sphere
Current Medicinal Chemistry Targeted Therapies in Solid Tumours: Pinpointing the Tumours Achilles Heel
Current Pharmaceutical Design Aflibercept (VEGF-TRAP): The Next Anti-VEGF Drug
Inflammation & Allergy - Drug Targets (Discontinued) Factors Affecting the Metabolite Productions in Endophytes: Biotechnological Approaches for Production of Metabolites
Current Medicinal Chemistry Nanomedicines Based Drug Delivery Systems for Anti-Cancer Targeting and Treatment
Current Drug Delivery Proteomics and Epigenetic Mechanisms in Stem Cells
Current Proteomics IL-13 and its Signal Pathway: Promising Targets in the Development of a Therapeutic Agent for Bronchial Asthma
Current Signal Transduction Therapy Molecular Targeting of Drug Delivery Systems to Cancer
Current Drug Targets MYC as Therapeutic Target for Embryonal Tumors: Potential and Challenges
Current Cancer Drug Targets TRPV1 Function in Health and Disease
Current Pharmaceutical Biotechnology Ring Finger Ubiquitin Protein Ligases and Their Implication to the Pathogenesis of Human Diseases
Current Pharmaceutical Design Sublethal Total Body Irradiation Leads to Early Cerebellar Damage and Oxidative Stress
Current Neurovascular Research In Vitro Evidence for Competitive TSPO Binding of the Imaging Biomarker Candidates Vinpocetine and Two Iodinated DAA1106 Analogues in Post Mortem Autoradiography Experiments on Whole Hemisphere Human Brain Slices
Current Radiopharmaceuticals Clinical Trials with Oncolytic Adenovirus in China
Current Cancer Drug Targets Biomedical Technologies for In Vitro Screening and Controlled Delivery of Neuroactive Compounds
Central Nervous System Agents in Medicinal Chemistry